Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.3 - $3.58 $22,054 - $60,734
16,965 New
16,965 $40,000
Q2 2023

Aug 11, 2023

BUY
$2.15 - $3.49 $427,153 - $693,379
198,676 New
198,676 $454,000
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $88,403 - $156,301
45,569 New
45,569 $109,000
Q2 2022

Aug 12, 2022

SELL
$1.31 - $2.69 $317,296 - $651,547
-242,211 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.95 - $3.89 $274,267 - $547,128
140,650 Added 138.49%
242,211 $506,000
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $386,947 - $625,615
101,561 New
101,561 $400,000
Q3 2020

Nov 13, 2020

SELL
$1.44 - $2.1 $45,449 - $66,280
-31,562 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.75 - $2.3 $55,233 - $72,592
31,562 New
31,562 $62,000
Q4 2019

Feb 14, 2020

SELL
$3.16 - $5.15 $51,710 - $84,274
-16,364 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.2 - $6.66 $19,636 - $108,984
16,364 New
16,364 $49,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.